Nucleic acid therapies: Cross-species optimization of viral vector-based gene editing in the heart
- Funding ID
81X2500403
- Project number
1834
- Institution
- Europäisches Laboratorium für Molekularbiologie (EMBL)
- Project leader
- Lars Steinmetz
- Site
- Heidelberg/Mannheim
- Project type
- Innovation Cluster
- Funding
- € 223.357,68
- Begin
- 01.01.2024
- End
- 31.12.2026
- Partner projects